AApoAII amyloidosis

Get in touch with RARE Concierge.

Contact RARE Concierge

Synonyms: Apolipoprotein A-II amyloidosis | Familial amyloid nephropathy due to apolipoprotein A-II variant | Familial renal amyloidosis due to apolipoprotein A-II variant | Hereditary amyloid nephropathy due to apolipoprotein A-II variant | Hereditary renal amyloidosis due to apolipoprotein A-II variant

A rare hereditary amyloidosis with primary renal involvement characterized by variable onset of renal insufficiency with edema hypertension proteinuria and azotemia eventually leading to end-stage renal disease. Amyloid cardiomyopathy and histopathological evidence of amyloid deposition in other organs such as the spleen liver adrenal glands and pancreas among others have also been described.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version June 2024

Newly diagnosed with
AApoAII amyloidosis?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

New Zealand Amyloidosis Patients Association

To make a positive and lasting impact in New Zealand, helping Amyloidosis disease patients from various disease subgroups ( AL, AA, hATTR, Wild Type) by working with local and international doctors, pharma treatment entities, as well as government agencies to bring approved funded treatment drugs into NZ for suffering patients. We desire to help build a lasting support system within the NZ health framework. We want an excellent wrap-around network of care to achieve for the sufferer to achieve a positive outcome in their well-being. This mission includes the wellness of the patient's caregiver and family whose needs, we feel, have been neglected.

Don't see your organization here. Let us know here.

Clinical Trials

For a list of clinical trials in this disease area, please click here.